Boehringer Ingelheim Vetmedica Inc. is recalling 16,633 tubes of Surpass (1% diclofenac sodium) Topical Anti-Inflammatory Cream for horses. During stability testing, the medication was found to be 'out of specification,' meaning the product may not meet the quality and potency standards required for its intended use. This recall affects 124-gram tubes sold in 33 states across the U.S. under Lot # 130502 with an expiration date of May 2015.
Because the product is out of specification, it may not provide the expected anti-inflammatory benefits or could have altered chemical properties, potentially impacting the effectiveness of treatment for the animal.
Veterinary drug refund and guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response